scispace - formally typeset
M

Mariam M. Konaté

Researcher at National Institutes of Health

Publications -  17
Citations -  433

Mariam M. Konaté is an academic researcher from National Institutes of Health. The author has contributed to research in topics: NADPH oxidase & Cancer. The author has an hindex of 9, co-authored 13 publications receiving 181 citations. Previous affiliations of Mariam M. Konaté include Columbia University.

Papers
More filters
Journal ArticleDOI

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository.

TL;DR: This is the first comparative study of RNA-seq data quantification measures conducted on PDX models, which are known to be inherently more variable than cell line models, and results reveal that hierarchical clustering on normalized count data tended to group replicate samples from the same PDX model together more accurately than TPM and FPKM data.
Journal ArticleDOI

Inhibiting the Activity of NADPH Oxidase in Cancer.

TL;DR: This work has shown that large drug screens and rational design efforts have yielded inhibitor compounds, such as the diphenylene iodonium (DPI) analog series developed by the group, with increased selectivity and potency over "first generation" NOX inhibitors such as apocynin and DPI.
Journal ArticleDOI

Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases

TL;DR: Iodonium analogs with anticancer activity, including the first generation of targeted agents with improved specificity against DUOX2, may provide a novel therapeutic approach to NOX-driven tumors.